Walleye Capital
CRMD icon

Walleye Capital’s CorMedix CRMD Stock Holding History

Walleye Capital’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-15,971
Closed -$63.3K – 4951
2023
Q2 		$63.3K Buy
+15,971
New +$79K ﹤0.01% 3579
2022
Q3 		– Sell
-48,000
Closed -$193K – 3267
2022
Q2 		$193K Buy
+48,000
New +$178K 0.01% 1533
2022
Q1 		– Sell
-11,200
Closed -$51K – 2340
2021
Q4 		$51K Buy
+11,200
New +$55.6K ﹤0.01% 1774

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $22.7B AUM 59.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Walleye Capital's CRMD Position: Q3 2023 in Review

Walleye Capital sold out of CorMedix (CRMD) in Q3 2023, closing a stake of 15,971 shares — an estimated $63.3K sold.

Walleye Capital first reported a position in CRMD in Q4 2021 and held it in 3 quarters. The position peaked at $193K in Q2 2022. 92 funds tracked by Wall St. Rank hold CRMD as of Q3 2023.

  • Walleye Capital reported no remaining CorMedix position as of Q3 2023 after selling out during the quarter.
  • Walleye Capital sold 15,971 CorMedix shares in Q3 2023, an estimated $63.3K.
  • Walleye Capital first reported a position in CorMedix in Q4 2021 and held it in 3 quarters.
  • Walleye Capital's CorMedix position peaked at $193K in Q2 2022.
  • 92 funds tracked by Wall St. Rank held CorMedix as of Q3 2023.

Based on Walleye Capital's 13F filing for Q3 2023, filed 14 Nov 2023.